Partnering with Satori

Satori is led by a world class management team with deep CNS drug discovery and development experience that, combined, has helped develop over 100 clinical candidates and more than 10 approved drugs. Satori's management team employs a top of industry approach to the development of its drug candidates – utilizing clinical strategies that are familiar to pharmaceutical companies working in AD.

Satori understands what pharmaceutical companies require for effective clinical development and understands the inherent value of strategic partners. Successful collaborations are a critical means to achieve Satori's goal of bringing forward life-changing therapeutics for Alzheimer's Disease (AD).

Satori is proud of its partnerships with both academic and industry collaborators to date. We view them as a key strategy for success.

Satori will continue to augment its significant internal capabilities by collaborating with partners with a shared commitment to excellence in the discovery and development of novel products. We are actively seeking:

• Partnerships that will further accelerate our own internal scientific discovery and drug development efforts.
  
  
• Partnerships that will bolster our pipeline of first- or best-in-class products to treat diseases or disorders of the central nervous system.

We welcome the chance to explore partnership opportunities with interested parties. Please contact us at partnering@satoripharma.com to request additional information on partnering with us or to initiate a discussion with our team.